Analyze Diet
Forensic science international2025; 374; 112545; doi: 10.1016/j.forsciint.2025.112545

Detection using chamber digital PCR with a DNA extraction-free method for gene-doping control.

Abstract: Gene doping, which entails the administration of transgenes, poses a serious threat to the integrity of equine sports and also raises both ethical and regulatory concerns. Current methods used for the detection of such doping often necessitate the extraction of DNA from plasma, which can be time-consuming and labour-intensive. To overcome this limitation, we developed a direct chamber digital PCR (cdPCR) method that enables transgene detection in equine plasma without the need for DNA purification. Using the equine erythropoietin (EPO) transgene as a model, we validated the assay by analysing plasma samples spiked at 10-1000 copies/µL. Samples were pre-treated with Lysis Buffer S Ver.2 and used directly as templates for cdPCR, employing a hydrolysis probe targeting an exon-exon junction of the transgene. This method required only 0.55 µL of plasma per 10 µL reaction and enabled us to achieve consistent detection down to 1000 copies/µL with high reproducibility and low background interference. The assay also proved effective in detecting the EPO transgene in plasma collected from a Thoroughbred horse after intramuscular plasmid administration. Compared with conventional PCR-based methods, this protocol substantially reduces sample handling and processing times, without any appreciable decrement in sensitivity. Our findings indicate the potential utility of direct cdPCR as a practical tool for gene doping surveillance in equine sports. Its simplified workflow and minimal sample requirement also suggest broader applications in forensic biotechnology, for which rapid and reliable detection of genetic material is essential.
Publication Date: 2025-06-25 PubMed ID: 40592127DOI: 10.1016/j.forsciint.2025.112545Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article discusses the development and testing of a new method for detecting gene doping in horses which is simpler and faster than current standard methods. The newly developed method, known as direct chamber digital PCR (cdPCR), doesn’t require DNA extraction from plasma samples, making the detection process quicker and easier.

Research Process

  • The researchers set out to create a new method to identify the presence of gene doping in equine sports, using direct cdPCR technology that doesn’t require the time-consuming process of extracting DNA from blood plasma samples.
  • They tested the method with a known gene doping agent, equine erythropoietin (EPO), that is a type of transgene (genetic material transferred from one organism to another).
  • The assay or chemical test was validated by analysing plasma samples spiked with varying concentrations of the EPO transgene, between 10-1000 copies/µL.

Method and Results

  • The study used a method involving treating the samples with a lysis buffer solution and then using these samples directly as templates for cdPCR tests.
  • A hydrolysis probe specifically designed to target an exon-exon junction of the transgene was used, meaning the cdPCR could accurately detect the transgene if present.
  • Prior to analysis, only a small plasma sample was required (0.55 µL per 10 µL reaction). They successfully detected up to 1000 copies/µL with high reliability and without any background interference.
  • The method was effective in detecting the EPO transgene in plasma samples collected from a purebred racehorse after it was given the altered plasmid intramuscular.

Implications

  • Compared with traditional PCR-based methods, this new method substantially reduces the time and effort spent on sample processing without decreasing sensitivity.
  • The researchers suggest that this new method could become a practical tool for gene doping control in equine sports.
  • The simplified process and reduced need for samples also indicate that this method could be applied in forensic biotechnology, where the rapid and reliable detection of genetic material is important.

Cite This Article

APA
Furukawa R, Tozaki T, Kawate K, Kikuchi M, Ishige T, Takahashi Y, Fukui E, Kakoi H. (2025). Detection using chamber digital PCR with a DNA extraction-free method for gene-doping control. Forensic Sci Int, 374, 112545. https://doi.org/10.1016/j.forsciint.2025.112545

Publication

ISSN: 1872-6283
NlmUniqueID: 7902034
Country: Ireland
Language: English
Volume: 374
Pages: 112545
PII: S0379-0738(25)00183-5

Researcher Affiliations

Furukawa, Risako
  • Genetic Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan. Electronic address: r-furukawa@lrc.or.jp.
Tozaki, Teruaki
  • Genetic Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.
Kawate, Koki
  • Genetic Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.
Kikuchi, Mio
  • Genetic Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.
Ishige, Taichiro
  • Genetic Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.
Takahashi, Yuji
  • Equine Research Institute, Japan Racing Association, Shimotsuke, Tochigi, Japan.
Fukui, Emiko
  • School of Agriculture, Utsunomiya University, Utsunomiya, Tochigi, Japan.
Kakoi, Hironaga
  • Genetic Analysis Department, Laboratory of Racing Chemistry, Utsunomiya, Tochigi, Japan.

MeSH Terms

  • Animals
  • Doping in Sports
  • Horses / genetics
  • Horses / blood
  • Erythropoietin / genetics
  • Erythropoietin / blood
  • Polymerase Chain Reaction / methods
  • Transgenes
  • DNA / blood
  • DNA / isolation & purification
  • Plasmids
  • Reproducibility of Results

Conflict of Interest Statement

Declaration of Competing Interest The QuantStudio Absolute Q Digital PCR System was leased free of charge from Thermo Fisher Scientific, Japan, as a demonstration for two months. Additionally, the Absolute Q™ Universal DNA Digital PCR Master Mix (5X) and MAP16 plates were partially provided by Thermo Fisher Scientific, Japan, for this study. The authors declare no other competing interests.

Citations

This article has been cited 0 times.